India's pharma and chemical companies are now set to integrate deeper into global supply chains, and back integrate, with China plus one initiative and other regulations, triggering more investments. Though supply chain shocks could derail these early success stories, a deep dive at a recent thought leadership conclave revealed many opportunities and strategies to tackle the challenges.
Express Pharma, in partnership with Indian Pharmaceutical Alliance (IPA) and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave titled, Reimagining Spend Management & Supply Chain for Pharma and Chemical Industry. Cross functional experts explored how smart supply chain technology optimises spends and maximises global growth opportunities, extracted learnings from success stories, and shared real-world experience and solutions to evolve up the global pharma value chain.
Speakers explored how they could pivot materials and export logistics to the next level with advanced supply chain technology, and shared success stories highlighting greater gains from supply chain technology and automation. They also explored how smart AI contracting across the pharma and chemicals supplier universe could link spends, RoI and result in value creation. There was broad consensus on the critical need for technology material traceability to insulate pharma and chemical exports from supply chain shocks.
In a Fireside chat, titled Future Proofing the Chemicals and Pharma Supply Chains, moderated by Viveka Roychowdhury, Editor, Express Pharma and Express Healthcare, two association chiefs discussed the impact of COVID-19 on the pharmaceutical and chemical supply chains, highlighting the invaluable lessons learned for future policy formulation.
Esta historia es de la edición November 2024 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición November 2024 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
Complete environmental monitoring solution - testo Saveris Pharma
testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.
